英文論文
1.Yoneyama S, Sakurada Y, Kikushima W, Sugiyama A, Matsubara M, Fukuda Y, Tanabe N, Parikh R, Mabuchi F, Kashiwagi K, Iijima H. Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Sci Rep 10:7188
2.※Ying Tang, Zhenyang Zhu, Toyoura M, Go K, Kashiwagi K, Fujishiro I, Xiaoyang Mao. ALCC-Glasses: Arriving Light Chroma Controllable Optical See-Through Head-Mounted Display System for Color Vision Deficiency Compensation. Applied Sceinces10（７）：1-15
3.※Xi Zhao, Fujishiro I, Go K, Toyoura M, Kashiwagi K, Xiaoyang Mao. Enhancing visual performance of hemianopia patients using overview window. Computers & Graphics 89：59-67
4.Kikushima W, Sugiyama A, Yoneyama S, Matsubara M, Fukuda Y, Parikh R, Sakurada Y. Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy. PLoS One 15（２）
5.※Sumit Randhir Singh, Ravi Parikh, Sakurada Y, Bhushan Uplanchiwar, Ahmad Mansour, Abhilash Goud, Yasha S Modi, Jay Chhablani. Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year. Taiwan J Ophthalmol 4（１０）：289-293
6.Shijo T, Sakurada Y, Yoneyama S, Kikushima W, Sugiyama A, Matsubara M, Fukuda Y, Mabuchi F, Kashiwagi, K. Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration. Pharmaceuticals (Basel)13（９）
7.Shijo T, Sakurada Y, Fukuda Y, Yoneyama S, Sugiyama A, Matsubara M, Kikushima W, Tanabe N, Parikh R, Kashiwagi K. Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration Int Ophthalmol 40（10）：2735-2742
8.Sakurada Y, Parikh R, Gal-Or O, Balaratnasingam C, Leong B. C. S, Tanaka K, Cherepanoff S, Spaide R. F, Freund K. B, Yannuzzi L. A. CUTICULAR DRUSEN: Risk of Geographic Atrophy and Macular Neovascularization. Retina 40（２）：257-265
9.Sakurada Y, Mabuchi F, Kashiwagi K. Genetics of primary open-angle glaucoma and its endophenotypes. Prog Brain Res 256（1）：31-47
10.Sakurada Y, Fragiotta S, Leong B.C.S, Parikh R, Hussnain S.A, Freund K. B. Relationship between Choroidal Vascular Hyperpermeability, Choriocapillaris Flow Density, and Choroidal Thickness in Eyes with Pachychoroid Pigment Epitheliopathy. Retina 40（4）：657-662
11.※Asaoka R, Murata H, Asano S, Matsuura M, Fujino Y, Miki A, Tanito M, Mizoue S, Mori K, Suzuki K, Yamashita K, Kashiwagi K, Shoji N. The usefulness of the Deep Learning method of variational autoencoder to reduce measurement noise in glaucomatous visual fields. Scientific Reports 10
12.Matsubara M, Sakurada Y, Sugiyama A, Fukuda Y, Parikh R, Kashiwagi K. Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results. PLoS One 15(8)
13.Mabuchi F, Mabuchi N, Sakurada Y, Yoneyama S, Kashiwagi K, Iijima H, Yamagata Z, Takamoto M, Aihara M, Iwata T, Hashimoto K, Sato K, Shiga Y, Nishiguchi K.M, Nakazawa T, Akiyama M, Kawase K, Ozaki M, Araie M, for the Japan Glaucoma Society Omics Group (JGS-OG). Genetic Variants Associated With the Onset and Progression of Primary Open-Angle Glaucoma. Am J Ophthalmol 215:135-140
14.※Lizhu Yang, Fujinami K, Ueno S, Kuniyoshi K, Hayashi T, Kondo M, Mizota A, Naoi N, Shinoda K, Kameya S, Yu Fujinami-Yokokawa, Xiao Liu, Gavin Arno, Nikolas Pontikos, Kominami T, Terasaki H, Sakuramoto H, Katagiri S, Mizobuchi K, Nakamura N, Mawatari G, Kurihara T, Tsubota K, Miyake Y, Yoshitake K, Iwata T, Tsunoda K ,JEGC study group（Kashiwagi Kを含む). Genetic Spectrum of EYS-associated Retinal Disease in a Large Japanese Cohort: Identification of Disease-associated Variants with Relatively High Allele Frequency. Scientific Reports 10
15.Kotoda Y, Ogiwara M, Kinouchi M, Iijima H. Left-Right and Upper-Lower Light Sensitivity Asymmetry in Visual Field Defects Caused by Pituitary Adenoma: A Retrospective Observational Study. Clin Ophthalmol 14:317-324
16.Kashiwagi K, Chono E, Sarah Koesters, Poh Sin Yap. Persistence and Treatment Patterns of Fixed Combination Drugs for Glaucoma: A Retrospective Claims Database Study in Japan. BMC Ophthalmology 20(223)
17.Kashiwagi K, Iizuka Y. Effect and underlying mechanisms of airborne particulate matter 2.5 (PM2.5) on cultured human corneal epithelial cells. Sci Rep 10:19516
18.Kume A, Kashiwagi K. Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus. BMC Ophthalmology 20
19.Kume A, Kashiwagi K. Recent Epidemiological Status of Ocular and Other Major Complications Related to Diabetes Mellitus in Japan. Ophthalmologica 204(6):404-412
20.※Fung A. T, Waldstein S. M, Gal-Or O, Pellegrini M, Preziosa C, Shields J. A, Welch R. J, Dolz-Marco R, Sarraf D, Nagiel A, Lalane R, Jung J. J, Ghazi N. G, Ramtohul P, Arnold J. J, Sakurada Y, Choudhry N, Balaratnasingam C, Freund K. B, Shields C. L. FocalScleral Nodule: A New Name for Solitary Idiopathic Choroiditis and Unifocal Helioid Choroiditis. Ophthalmology 127(11):1567-1577
21.Fukuda Y, Sakurada Y, Sugiyama A, Yoneyama S, Matsubara M, Kikushima W, Tanabe N, Parikh R, Kashiwagi K. Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy. J Clin Med 9(8)
22.※Keisuke Ichinose, Issei Fujishiro, Kenji Kashiwagi, Xiaoyang Mao Xiaoyang, Xi Zhao, Masahiro Toyoura, Kentaro Go. Visual Field Loss Compensation for Homonymous Hemianopia Patients Using Edge Indicator. International Conference on Cyberworlds (CW)
23.※Lina Chen, Kentaro Go, Yuichiro Kinoshita, Kenji Kashiwagi, Masahito Toyoura, Issei Fujishiro, Xiaoyang Mao. Using an Eye Tracking Device to Discriminate Different Symptoms in Glaucoma. International Conference on Cyberworlds (CW)
24.※Fujinami-Yokokawa Y, Fujinami K, Kuniyoshi K, Hayashi T, Ueno S, Mizota A, Shinoda K, Arno G, Pontikos N, Yang L, Liu X, Sakuramoto H, Katagiri S,Mizobuchi K, Kominami T, Terasaki H, Nakamura N, Kameya S, Yoshitake K, MiyakeY, Kurihara T, Tsubota K, Miyata H, Iwata T, Tsunoda K; Japan Eye Genetics Consortium(K.Kashiwagiを含む). Clinical and Genetic Characteristics of 18 Patients from 13 Japanese Families with CRX-associated retinal disorder: Identification of Genotype-phenotype Association. Scientific Reports 10（9531）
25.※Ryo Asaoka, Hiroshi Murata, Masato Matsuura, Yuri Fujino, Atsuya Miki, Masaki Tanito, Shiro Mizoue, Kazuhiko Mori, Katsuyoshi Suzuki, Takehiro Yamashita, Kenji Kashiwagi, Nobuyuki Shoji. Usefulness of data augmentation for visual field trend analyses in patients with glaucoma. Br J Ophthalmol. 104(12):1697-1703
26.※Yohei Tomita, Zhuo Shao, Bertan Cakir, Yumi Kotoda, Zhongjie Fu, Lois E H Smith. An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis. Journal of Visualized Experiments 2020.Aug 6;(162)
※は他施設での業績、下線が山梨大学眼科学教室の共著者
和文論文
1.松本瑞紀、飯島裕幸. 裂孔原性網膜剥離の男性比率 山梨大学医学部附属病院17年間の手術統計から. 眼科 62（7）：701-708
2.加茂純子、村松志保、赤澤博美、阿部水穂. 感受性からみた年齢別眼科領域抗菌薬選択 2018.あたらしい眼科 37：484-489
3.原吉幸、玉木光子、原育子、加茂純子. はつゆき草樹液による眼障害の3例. 臨床眼科 74：615-619
4.加茂純子、遠藤勝久、原田亮. Colenbrander-Endoh-Kamo Functional Vision Score計算シートの試行. 眼科臨床紀要
5.加茂純子、大坪優太、藤田大輔、萩原妃里子、山田洋二、原田亮、濱田悠太. 病院、介護施設でリハビリ・介護を受ける患者の視機能スクリーニングに要する時間. 視覚障害リハビリテーション協会誌 9(2):29-34
6.原田亮、加茂純子. OCTOPUS 900 視野計を用いた静的視野によるVisual Field Score Functional Field Scoreの測定. 臨床眼科 74（10）：1286-1295
総説/著書
1.北村一義、柏木賢治 原発閉塞隅角症（緑内障）の急性発作 眼科 2020年10月臨時増刊号 眼科救急疾患2020 62（11）：1161-1165
2.柏木賢治 日本眼科学会主導のビッグデータ集約システム 眼科グラフィック9（5）：543-547
3.柏木賢治 わかりやすい臨床講座 緑内障におけるAIの活用 日本の眼科91（4）：50-54
4.柏木賢治 【人工知能(AI)と眼科医療】わかりやすい臨床講座 緑内障におけるAIの応用日本の眼科91（4）：514-518
5.柏木賢治 前房深度検査 眼科学3：183-185
6.加茂純子(編集：千原悦夫、辻川明孝、谷戸正樹） 小児、障害者の視力測定 みんなの眼科検査メモ:27-28
その他
1.飯島裕幸 なんでも健康相談 眼底出血の治療を受けました。今後の進行が心配です NHKテキスト きょうの健康392：102
2.柏木賢治 教室運営にあたって 地方大学のこれからの役割と取り組み 従来の眼科学の枠組みを超えた成果を 銀海252号
3.柏木賢治 P2Y6受容体の遺伝子改変を利用した新しい緑内障モデル 山梨大学新技術説明会(2020.12.3）
4.加茂純子、塩澤未佳子 【ラジオ出演】zoomによるロービジョンケア講習会について 山梨放送ラジオライトハウス(2020.6.6)